Skip to main content
Contact Us
Subscribe
E-Edition
81°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
191.90
-3.10 (-1.59%)
Streaming Delayed Price
Updated: 10:37 AM EDT, Jul 11, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about AbbVie
< Previous
1
2
3
4
5
6
7
8
9
...
74
75
Next >
Recent Filing Shows That Rep. Robert Bresnahan Bought Over $28K Worth of AbbVie Stock
June 10, 2025
Via
Benzinga
1 S&P 500 Stock with Competitive Advantages and 2 to Steer Clear Of
June 09, 2025
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural...
Via
StockStory
Topics
Economy
Stocks
3 Stocks With Mouthwatering Dividends You Can Buy Right Now
June 08, 2025
Via
The Motley Fool
Topics
Intellectual Property
Billionaire Ken Griffin Just Bought More Shares of These Unstoppable Dividend Stocks
June 05, 2025
Via
The Motley Fool
Topics
Economy
World Trade
A Look Into AbbVie Inc's Price Over Earnings
May 13, 2025
Via
Benzinga
AnaptysBio's Arthritis Drug Matches Top Therapies In Phase 2 Trial, Analyst Sees Turning Point
June 04, 2025
Rosnilimab met key RA trial goals, with sustained clinical responses and safety benefits, prompting an analyst upgrade and price target hike to $38.
Via
Benzinga
9 Health Care Stocks Whale Activity In Today's Session
June 04, 2025
Via
Benzinga
3 Cheap Dividend Growth Stocks to Buy Right Now
June 04, 2025
Via
The Motley Fool
Topics
Economy
4 Forever Dividend Stocks to Buy
June 03, 2025
These companies provide growing cash flows.
Via
The Motley Fool
Meta, JPMorgan, Gap And A Health Care Stock On CNBC's 'Final Trades'
June 02, 2025
Via
Benzinga
Novo Nordisk Is Shedding Muscle In The Weight-Loss Brawl With Eli Lilly
May 29, 2025
Eli Lilly is rapidly encroaching on Novo Nordisk's yearslong lead in GLP-1 drugs. Can Novo hold its tentpole position?
Via
Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
May 28, 2025
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
May 27, 2025
Via
Benzinga
AbbVie To Present Cancer Trial Data At Upcoming ASCO Event
May 27, 2025
AbbVie shares new data for Temab-A, ABBV-706, and PVEK across lung, colorectal, and blood cancers ahead of the ASCO oncology conference.
Via
Benzinga
U.S. Pharmaceutical Imports Might Soon Face Tariffs: 3 Stocks That Could Tumble as a Result
May 24, 2025
There's little doubt these pharmaceutical companies' costs will soon be rising at least a little.
Via
The Motley Fool
Topics
Government
Supply Chain
World Trade
Elon Musk Commits to Tesla. Is That a Good Thing?
May 23, 2025
Via
The Motley Fool
2 Incredible Dividend Growth Stocks to Buy Now
May 21, 2025
Via
The Motley Fool
Topics
Government
Intellectual Property
10 Health Care Stocks With Whale Alerts In Today's Session
May 20, 2025
Via
Benzinga
Don't Fall for These 3 Dividend Stocks: They May Have to Make a Cut.
May 18, 2025
Here are three dividend-paying stocks that warrant closer examination.
Via
The Motley Fool
3 Magnificent Stocks That Are Passive Income Machines
May 17, 2025
Via
The Motley Fool
3 Stocks That Will Profit From Trump's Drug Price Cut
May 16, 2025
Trump's EO aims to lower US drug prices by using leverage of public programs (like Medicare) to force accountability. Big pharma may be hit hardest.
Via
Benzinga
Topics
Government
1 Healthcare Stock to Keep an Eye On and 2 to Ignore
May 16, 2025
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory...
Via
StockStory
Topics
Economy
Stocks
Why Pfizer Is Poised For A Strong Comeback: My Top Pick For 2025
May 15, 2025
For investors willing to look beyond the current negative sentiment, Pfizer at today's prices represents a rare buying opportunity.
Via
Benzinga
Jim Cramer Says Even 'Safety' Stocks Look Risky, Warns Of 'Wild Card' In Washington And Rising Treasury Yields As Reasons To Stay Away From Sure Bets
May 15, 2025
Rising bond yields and uncertain politics make 'safety' stocks less appealing, says Jim Cramer. Even Procter & Gamble and Johnson & Johnson suddenly feel shaky to the market guru.
Via
Benzinga
Topics
Bonds
Stay informed with the top movers within the S&P500 index on Wednesday.
May 14, 2025
Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Wednesday as we examine the latest happenings in today's session.
Via
Chartmill
FDA Fast-Tracks AbbVie's New Lung Cancer Therapy Emrelis For Tough Lung Cancer Cases
May 14, 2025
FDA grants accelerated approval to AbbVie's Emrelis for c-Met overexpressing NSCLC; siRNA partnership with ADARx includes $335 million upfront.
Via
Benzinga
AbbVie Gets FDA Nod For Drug To Treat Lung Cancer: Retail’s Yet To React
May 14, 2025
The company also announced a collaboration and license option agreement with ADARx Pharmaceuticals to develop small interfering RNA (siRNA) therapeutics across multiple disease areas, including...
Via
Stocktwits
What's going on in today's session: S&P500 movers
May 14, 2025
Curious about the top performers within the S&P500 index in the middle of the day on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Via
Chartmill
Expert Outlook: AbbVie Through The Eyes Of 10 Analysts
May 14, 2025
Via
Benzinga
Q1 Therapeutics Earnings: United Therapeutics (NASDAQ:UTHR) Impresses
May 13, 2025
As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the therapeutics industry, including United Therapeutics (NASDAQ:UTHR) and its peers.
Via
StockStory
Topics
Artificial Intelligence
< Previous
1
2
3
4
5
6
7
8
9
...
74
75
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.